Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Jul 9.
Published in final edited form as: Structure. 2025 Jun 5;33(8):1314–1324.e5. doi: 10.1016/j.str.2025.05.007

Structural insights into functional regulation of the human CPEB3 prion by an amyloid-forming segment

Maria D Flores 1,*, Michael R Sawaya 2, David R Boyer 2, Samantha Zink 1, Susanna Tovmasyan 1, Adrian Saucedo 1, Logan S Richards 1, Chih-Te Zee 1, Jorge Cardenas 1, Luana Fioriti 3,4,*, Jose A Rodriguez 1,*
PMCID: PMC13344147  NIHMSID: NIHMS2086456  PMID: 40480223

Summary:

The cytoplasmic polyadenylation-element-binding-protein-3 (CPEB3) is a functional prion thought to modulate protein synthesis and enable consolidation of long-term memory in neurons. We report a cryo-EM structure of amyloid fibrils grown in vitro from the first prion-like domain of human CPEB3 (hCPEB3), revealing their ordered 49-residue core, spanning L103 to F151. CPEB3 lacking that segment coalesces into abnormal puncta in cells compared to wildtype CPEB3, localizes away from dormant p-bodies and toward stress granules, and lacks the ability to influence protein synthesis in neurons. Fluorescence-guided cryo-FIB milling and cryo-ET applied to neuronal cells expressing CPEB3 reveal CPEB3-GFP signal from lamellae enriched in multivesicular bodies (MVBs), cavernous multilamellar compartments, and bundled filaments, suggesting a state of induced cellular stress. Accordingly, cells expressing wild-type CPEB3 are less viable than those expressing CPEB3 without its amyloid core, suggesting human CPEB3 regulation may be required to overcome the liability associated with its self-assembly in cells.

eTOC blurb:

Flores et al. investigate self-assembly of the hCPEB3 prion-like domain, determining the cryoEM structure of its labile amyloid fibrils. The amyloid-forming segment is critical for the protein’s translational regulation of target mRNAs and its proper distribution in cells. Overexpression of wild type hCPEB3 is cytotoxic and induces multilamellar subcellular compartments.

Graphical Abstract

graphic file with name nihms-2086456-f0006.jpg

Introduction:

Prions, or proteinaceous infectious particles1, are stable, long-lived, pathogenic or functional assemblies present in species across the tree of life2. Many prions rely on an amyloid architecture to recruit naïve proteins and template their conversion into ordered fibrillar β-sheet-rich assemblies 2,3. Because of their ability to adopt amyloid folds, prion-like proteins present a challenge to the proteostatic framework in neurons4. However, since prions can endure protein turnover, they can also influence the persistence of biochemical states that influence memory consolidation5.

Prion-based mechanisms have been described to influence learning and memory in Aplysia6, Drosophila7,8 and most recently, mammals9,10. Neuronal isoforms of the cytoplasmic polyadenylation element binding protein (CPEB), a functional prion, are involved in regulating localized translation at synapses4. In Drosophila, prion-like fibrillar aggregates of the CPEB ortholog, Orb2 display amyloid features, including steric zipper motifs. Their dry amyloid fibril core is formed by tightly mated sheets whose glutamine side chains interdigitate. The discovery of this structure supports the theory that CPEB orthologs can form persistent or stable amyloid assemblies, but leaves unknown the origin of these assemblies, their stability in cells, and the mechanism by which they avoid cytopathology11. Additionally, while these studies present remarkable views of functional prion structures in invertebrates, they offer limited insights into the prion-like function of mammalian CPEBs6,7,10. Vertebrate CPEBs (CPEB1–4) are RNA binding proteins that can promote the translation or repression of targets. CPEB1–4 have C-terminal RNA-binding domains, and variable N-terminal domains with intrinsically disordered regions12, and in the case of CPEB2 and CPEB3, are Q/N-rich.

CPEB3 is known to influence memory consolidation in mice and humans4,9,13,14. In mice, it is a 716-residue protein with two N-terminal prion-like domains linked by a short, low-complexity regulatory motif (Figure 1a). CPEB3 contains an N-terminal low complexity domain8, akin to those found in functional yeast prions2. The CPEB3 prion domains influence the activity of its two C-terminal RNA-binding domains and zinc finger domain8 (Figure 1a). As an RNA binding protein, CPEB3 regulates translation of target mRNAs that are required for synaptic plasticity and the growth of new synaptic spines9,15,16. CPEB3 also regulates its own translation, and its RNA transcript forms a self-cleaving ribozyme that regulates transcriptional and translation processes.17 CPEB3 requires its N-terminal, prion-like domain 1 (PRD1) to restore a wild-type aggregation phenotype and mediate long-term potentiation (LTP) in CPEB3-deficient cells, and to influence the persistence of memory in mice9, while a second prion domain (PRD2) may be involved in nuclear export and binding interactions16. CPEB3 aggregates are regulated in part through mono-ubiquitination15 and SUMOylation18; these allow for its proper activation and repression, respectively. In its basal state, CPEB3 is SUMOylated and is postulated to undergo phase separation when it colocalizes to p-bodies where it inhibits translation of target mRNAs16. Upon proper signal-induced activity, it is then ubiquitinated and shuttled to polysomes where it increases translation of its targets16. These observations support the notion that the structure, decoration and localization of prion-like CPEB3 assemblies are linked to its function.

Figure 1. CryoEM structure of fibrils formed by the human CPEB3 prion-like domain 1.

Figure 1.

a, Schematic summary of hCPEB3 domains. b, Amino acid sequence alignment of fibril core corresponding to secondary structure β-strands. c, Model of CPEB3AC filaments with a corresponding helical pitch of 536 Å. d, Top: cryoEM map of cross section perpendicular to the helical axis with model rendering colored to match secondary structure schematic. Bottom: side view of map and model measuring height different within one helical layer.

The prion-like nature of CPEB3 is supported by its formation of heritable aggregates in yeast10. Similar aggregates appear to be required for its function in neurons10. However, structural analyses of CPEB3 are limited. Our current view of mammalian CPEB3 prion structure is informed instead by sequence analysis and NMR spectroscopy, where sequence analysis reveals segments in the PRD1 of human CPEB3 that may form higher-order coiled-coiled ⍺-helical assemblies and whose self-assembly may involve actin binding19,20,21. In addition, NMR spectroscopy studies predict the presence of a β-rich ordered core formed by mouse CPEB3 spanning T101-S194, and indicate its propensity to form amyloid-like fibrils.22 However, these studies present a limited view of the physical state of CPEB3 in cells and of the atomic structures adopted by multimeric states of the CPEB3 prion-like domain.

With the goal of improving our understanding of CPEB3 functional prion-like mechanisms, we investigated the sequence of human CPEB3 PRD1 and found it capable of self-assembling into reversible amyloid fibrils in solution. The structure of these fibrils, determined by single particle cryoEM, showed an ordered core composed of hCPEB3 residues 103 to 151 arranged in a serpentine fold. The sequence composition of this amyloid core (AC) offered clues to its lability and possible sensitivity to environmental changes in pH. CPEB3 constructs lacking this AC sequence showed altered subcellular distribution, indicating a role for this sequence in hCPEB3 activity. This hypothesis was confirmed by the altered translational regulation of AC-deficient hCPEB3 in primary neurons. To improve our understanding of hCPEB3 assemblies in cells, we sought molecular snapshots of CPEB3-GFP inclusions in unstimulated U87 cells using cryo-focused ion beam (cryo-FIB) milling and correlative cryo-ET. We found CPEB3-GFP signal in lamellae that also contained an abundance of multivesicular bodies (MVBs) and dense fibrillar structures, vesicles and phase-separated droplets. Collectively, our observations support a model in which hCPEB3 function is regulated in part by its AC sequence in PRD1, and offer clues into the storage and regulation of prion-like inclusions in neuronal cells.

Results:

CPEB3 PRD1 forms amyloid fibrils in vitro.

Hypothesizing that CPEB3 PRD1 may form functional amyloid assemblies23, we expressed and isolated a construct of human CPEB3 (hCPEB3) encoding its first 217 residues that included the entirety of its conserved PRD1 (Supplementary Figure 1). This region of CPEB3 in mice has been previously identified as essential for prion-seeding and heritability,10 and is essential for LTP in mice9. We assessed the ability of this construct (hCPEB31–217) to form fibrils in vitro by enhanced fluorescence of the amyloid-binding dye ThT, and negative stain electron microscopy (Supplementary Figure 2). Under denaturing conditions containing high concentrations of guanidine or urea, hCPEB31–217 would precipitate as a heterogeneous mix of amorphous aggregates, twisting fibrils, or flat, ribbon like sheets (Supplementary Figure 3). However, in solutions containing 125 mM NaCl, 50 mM Tris-Base, 10mM K2HPO4 and 5 mM glutamic acid at pH 4.5 (assembly solution), hCPEB31–217 produced what appeared by negative stain electron microscopy to be fibrils with a homogenous twist (Supplementary Figure 2b). A survey of fibrils by atomic force microscopy (AFM) revealed a well dispersed population (Supplementary Figure 3a). To pursue structure determination in the face of this lability, fibrils were vitrified within an hour of formation in assembly solution.

Structure of the hCPEB3 amyloid fibril core

Solutions containing hCPEB31–217 fibrils were interrogated by single particle cryoEM, with the goal of de novo structure determination (Supplementary Figure 5). CryoEM images confirmed that hCPEB31–217 forms rapidly twisting amyloid fibrils in assembly buffer, with a single polymorph representing over 90% of imaged particles (Supplementary Figure 6a). The remaining 10% of species exhibited variable twist or no twist, and therefore eluded further classification and structure determination (Supplementary Figure 6b). Two-dimensional class averages confirmed canonical amyloid features corresponding to the stacking of β-sheets separated by ~4.8 Å inter-strand distances, as well as a disordered flanking region, or fuzzy coat, surrounding the fibril core (Supplementary Figure 6b). Three dimensional reconstructions obtained from 40,329 boxed fibril segments yielded a 3.0 Å map that showed density for a single asymmetric protofilament that fit residues L103-F151 of CPEB3, validated through sequence threading onto map (Figure 1a-b, Supplementary Figure 7). We refer to this structure and its corresponding core sequence as the hCPEB3 amyloid core (hCPEB3AC).

hCPEB3AC fibrils adopt a helical pitch of 536 Å and a left-handed twist of −3.32° (Figure 1c). AFM images confirmed the 268Å helical crossover and revealed the handedness of the fibrils (Supplementary Figure 3). In hCPEB3AC fibrils, molecules stack as strands, parallel and in register. The tight serpentine fold adopted by the hCPEB3AC core is enabled by five sharp kinks interspersed between its seven β-strands (Figure 1d). The core contains two hydrophobic pockets and encloses three internal solvent channels. It contains a total solvent accessible surface area per chain of 1653 Å2. At its N-terminus, L103 contacts a surface-facing segment of a beta turn in the fibril core, making a hydrophobic pocket composed of residues P105, F107, G126 and I127 (Supplementary Figure 8b). An additional hydrophobic pocket is formed by residues F124, V130, M134 and F136 (Supplementary Figure 8b). The core is further stabilized by stacking of aromatic residues including W111, F139, and F151, although some appear solvent facing. Polar residues T110, S112 and T116 face the largest solvent channel buried within the fibril core. A second, smaller solvent channel is lined by a group of largely hydrophobic residues: V119, P139, V143, P145; E120 stands as a lone hydrophilic residue in this group. This same glutamic acid forms part of a minute channel within the core, which is also lined by S122 and N138. The significance of E120 bridging these two solvent channels is unclear, but it could play a role in the lability of hCPEB3AC.

Structural features of CPEB1–217 fibrils

Energy values calculated using coordinates of the hCPEB3AC show that, per layer, this core is less stable than those of pathogenic amyloids (Supplementary Figure 8a)23. Estimates of its free energy are more in line with those of fibril structures formed by reversible, functional amyloids24–26. Solvent facing hydrophobic residues and buried solvent channels play a role in its predicted lability, but the hCPEB3AC is also strained by a series of kinks. Some of these kinks tilt strands out of plane, warping the layers of the fibril to create a height difference of 14.5 Å across each of its layers (Figure 1d, Supplementary Figure 8c). While the role of warping in amyloid fibril cores remains unclear, it may help relieve the strain associated with the large twist angle observed in hCPEB31–217 fibrils. In addition, some kinks appear to be stabilized by local interactions. For example, a kink near G114 facilitates hydrogen-bonding between side chains of S112 and T116 (Figure 1). Four of the 28 proline residues in hCPEB31–217 are resolved in the core (Figure 1). The remaining 24 proline residues are unresolved in the fuzzy coat extending from the CPEB3AC and may function to limit the size and stability of the ordered core. They appear as smeared density in 2D averages of hCPEB31–217 fibrils (Supplementary Figure 6b). While some of these regions are hypothesized to form coiled-coils19, that region of the map remains insufficiently resolved to be used for secondary structure assignment.

The role of negatively charged residues in CPEBAC

We observed four potentially charged residues in hCPEB3AC: two histidine residues (H141 and H142) are solvent exposed, and two acidic residues (E120 and D121) are buried within the fibril core (Supplementary Figure 8a). The two histidine residues are located too far from the acidic residues for charge complementarity to stabilize the fold. E120 is located in the second solvent channel and is otherwise surrounded by hydrophobic residues, while D121 faces the opposing solvent channel (Supplementary Figure 8b). As hCPEB3AC aggregates at a pH of 4.5, E120 and D121, are anticipated to remain protonated within the fibril core and are capable of forming stabilizing hydrogen bonds. These same residues would render the core susceptible to pH-triggered changes, as observed with other functional amyloids such as pmel17 and β-endorphin23,27,28. However, we found hCPEB31–217 fibrils to be reversible, disassembling when diluted in water (Supplementary Figure 2c). ThT signal also generally diminished when hCPEB3AC fibrils were introduced to solutions with increased pH or as reduced ionic strength (Supplementary Figure 2); a decrease in fibril abundance that was also observed by negative stain EM (Supplementary Figure 4). This dissolution in response to changing environmental conditions is recapitulated by simulations tracking fibril stability over a period of 200 nanoseconds (Supplementary Figure 9a). In the simulations, interlayer distances in a 5-layer fibrillar hCPEB3AC structure are disrupted as a pH increases from 3 to 7; notably, displacements are observed in charged residues E120 and D121 (Supplementary Figure 9b).

To assess whether E120 and D121 influence the morphology, distribution, and abundance of hCPEB3 aggregates in cells, we expressed GFP-tagged full-length CPEB3 constructs encoding wild-type and E120/D121 variations, in HT22 cells (Figure 2a,b). In these cells, wild-type, GFP-fused CPEB3 formed fine, granular fluorescent puncta, as previously described (Figure 2c,2d, Figure 3b, Supplementary Figure 10a)10,16,29. Forty-eight hours after transduction, the fine puncta were supplanted by larger puncta (Supplementary Figure 10a). To probe the influence of acidic side chains at residues 120ED121 we expressed a hCPEB3 variant encoding 120QN121, which retains the polarity and size of the wild-type residues but ablates their negative charge. We also expressed a variant encoding 120AA121 to assess the effect of ablating polarity and reducing the size of wild-type residues. Puncta formed by both constructs differed morphologically from those formed by wild-type CPEB3-GFP under similar conditions (Figure 2c, Supplementary Figure 10). CPEB3-120QN121 generally formed irregularly sized and shaped puncta, while CPEB3-120AA121 formed fewer puncta that were intermediate in size and remained more circular after 24hrs (Figure 2d, Supplementary Figure 10c, 10d, Supplementary Figure 11). The effects of these residue substitutions on the size and distribution of CPEB3AC puncta implicate a functional role for E120 and D121 in hCPEB3 coalescence within cells.

Figure 2. The role of E120 and D121 in hCPEB3 puncta formation in cells.

Figure 2.

Wild-type hCPEB3-GFP shows fine, granular like aggregates in HT22 mouse hippocampal neurons after 24 hours of expression. a, Schematic of full-length hCPEB3 construct expressed in cells. b, Sequence alignment of AC region in FL constructs with corresponding mutated residues in red. c, hCPEB3-GFP WT and mutants (green) and nuclear staining (blue) in HT22 neurons. d, insets of panel c. Scale bar = 10 μM.

Figure 3. CPEB3AC regulates subcellular location of GFP-tagged hCPEB3 in cells and affects its translational regulation.

Figure 3.

a, Schematic representation of full-length constructs used in localization and translational assays. b, HT22 and U87 cells expressing WT (top) and AC (bottom) (green) and subsequent co-localization with anti-Dcp1a (yellow) and anti-G3BP (red) with nuclear stain (blue). c, HEK 293T cells inhibitory renilla luciferase assays (n =5–11 replicates per construct).) Graphs show the quantification of renilla/Firefly ratio, mean ± s.e.m. One-way ANOVA, followed by Tukey's multiple comparisons post hoc test, ** p<0.01, ****p<0.0001 vs GFP; # p< 0.05, ## p<0.01, vs CPEB3ΔAC. d, Renilla luciferase assays performed in primary neurons. (n=7 per condition). Graphs show the quantification of renilla/Firefly ratio, mean ± s.e.m. Two-way ANOVA, followed by Tukey's multiple comparisons post hoc test, * p< 0.05, ** p<0.01, vs CPEB3 unstimulated; ##p< 0.01 vs CPEB3 stimulated.

CPEB3AC is required for proper aggregation and localization in cells.

To further probe the functional relevance of hCPEB3AC in cells, we asked whether the presence of the AC sequence affected hCPEB3 aggregation. While CPEB3 is known to form aggregates of various sizes when overexpressed in cells9,10,16, a construct of hCPEB3 lacking its amyloid core, CPEB3ΔAC displayed a reduced capacity to form small aggregates (Supplementary Figure 10). Instead, this construct showed a delayed formation of larger aggregates as compared to wild-type hCPEB3 in HT22 cells (Supplementary Figure 10). This prompted us to determine whether the localization of CPEB3ΔAC differed from that of wild-type hCPEB3 in cells. Under normal conditions, CPEB3 is expected to localize in p-bodies16 that contain mRNAs and associated regulatory proteins. There, mRNAs are stored in a dormant state while they are trafficked to their destination to be translated, or can be degraded. Alternatively, hCPEB3 could reside in stress granules (SG), induced to promote cell survival by condensing translationally stalled mRNAs.30 We observed that wild-type CPEB3-GFP aggregates primarily colocalized with the de-capping coactivator and p-body marker, Dcp1a, in unstimulated cells (Figure 3b). In contrast, in mouse HT22 cells, aggregated CPEB3ΔAC primarily colocalized with the SG assembly endoribonuclease, G3BP, and minimally colocalized with the p-body marker, Dcp1a (Figure 3b). Similar localization patterns were observed in human U87 glioblastoma cells (Figure 3b).

CPEB3AC impacts translational regulation by CPEB3

CPEB3 is thought to exist in two or more distinct states that regulate its translational activity, a basal repressor state, and an aggregated or more active state14,31–33. In its basal state, CPEB3 represses translation of target mRNAs, is SUMOylated, and colocalizes to p-bodies. After neuronal stimulation CPEB3 undergoes de-SUMOylation, leaves p-bodies and is then shuttled to polysomes to promotes translation of targets16 . The increase in translational activity of hCPEB3 is thought to be facilitated by monoubiquitination of PRD1 by Neuralized-115. The ubiquitination site of CPEB3 is currently unknown and efforts to identify and characterize all SUMOylation sites18 have not yielded a complete understanding of their role in CPEB3 activity. Since hCPEB3AC is situated within PRD1, we postulated it may influence translational regulation by CPEB3. In evaluation of this hypothesis, we assessed translation of CPEB3 targets, comparing the impact of wild-type protein to CPEB3ΔAC. Translation of Renilla luciferase fused to the 3’UTR of two established targets of CPEB3 targets, GluA2 and SUMO2 3’ UTR, in HEK-293 cells, was inhibited by both wild-type CPEB3 and CPEB3 lacking PRD1 (ΔN) (Figure 3). In contrast, translation of the same targets was unaffected by CPEB3ΔAC. To evaluate whether the lack of repression was due to a loss of function, suggesting CPEB3ΔAC cannot repress translation, or a gain of function, where it promotes translation without need of stimulation, we co-expressed wild type and CPEB3ΔAC. Co-expression of wild-type hCPEB3 and CPEB3ΔAC in cells re-established the translational repression observed with the wild-type protein alone, indicating CPEB3ΔAC is acting as a loss of function mutant (Figure 3c).

Expression of wild-type hCPEB3 in primary neurons repressed translation of its targets in unstimulated cells (Figure 3d). To stimulate neurons, we used a protocol consisting of bath application of bicuculline and glycine, a chemical treatment that induces long-term potentiation (LTP) of synapses (cLTP)34. As expected, glycine-mediated cLTP induced the translation of CPEB3 targets (Figure 3d). In contrast, expression of CPEB3ΔAC under the same conditions ablated all translational regulation, rendering the protein essentially inactive in this capacity (Figure 3d). In fact, luciferase activity in the presence of CPEB3ΔAC was most the same as that of cells expressing GFP alone, indicating that the presence of CPEB3AC segment is critical in mediating a proper translation of CPEB3 targets.

Subcellular structure of U87 cells expressing CPEB3-GFP

Hypothesizing that the subcellular structure of U87 cells expressing CPEB3-GFP might offer clues into its structure and function in situ, we targeted fluorescent puncta in these cells for focused ion beam (FIB) milling and cryo electron tomography (cryoET). We reconstructed tomograms from cellular lamellae with associated CPEB3-GFP fluorescence. U87 cells grown directly on EM grids and expressing CPEB3-GFP formed fluorescent inclusions; after 24 hours of expression, grids were flash frozen and loaded onto a cryo-FIB-SEM instrument equipped with an integrated fluorescence objective that allowed targeting of sufficiently large cytoplasmic inclusions in cells (Supplementary Figure 12). We found that GFP signal was associated with lamellae containing distinct cellular structures, including: an enrichment of multivesicular bodies (MVBs), cavernous compartments, aligned cytoskeletal filaments, autophagic bodies and extensive networks of vesicles (Figure 4, Figure 5). Some of the observed MVBs contained densely packed structures, occasionally appearing to harbor fibrillar assemblies packed in tight parallel fashion and resembling yarn balls (Figure 4a, 4c). Neighboring these structures were also intralumenal vesicles and droplets (Figure 4d). Interestingly, MVBs were often found in clusters, in the vicinity of elongated membranes and droplets. Notably absent from all surveyed tomograms of CPEB3-GFP expressing cells were the large fibrillar inclusion bodies observed in cells expressing pathogenic amyloids35.

Figure 4. Cytoplasmic regions containing MVBs harbor filament-like clumps.

Figure 4.

a, Tomographic slice from U87 cells expressing CPEB3-GFP. Where ER= endoplasmic reticulum, Ac= actin, YB= yarn ball, D= droplet, Vs= vesicle and EM= elongated membrane. Color dashed squares highlighted in b, c, and d. Scale bar = 200 nm. b, Magnified inset from pink box in a, highlighting bundled actin filaments. c, Magnified inset from green box in a, highlighting bundled filament-like yarn balls. d, Magnified inset from blue box in a, highlighting small intralumenal vesicles in MVBs. Pink arrows indicate actin filaments, while dark green arrows point to yarn ball-like curly fibrils in MVBs, a light green arrow the MVB boundary, and purple arrows small vesicles. Scale bar from b, c and d = 50 nm.

Figure 5. Ordered layers and cavities make up structured sub-compartments.

Figure 5.

a, Tomographic slice of cytoplasmic region containing smaller compartments in U87 cells. Where MVB= multivesicular body, Mt= microtubule, D= droplet, Ac= actin, and C= compartment. Scale bar = 200nm. b, magnified inset from blue box in a, highlighting spiral entwining layers and blending of features. c, Magnified inset from yellow box in a, highlighting unknown densities. Scale bar = 120nm. d, Tomographic slice of cytoplasmic region containing larger, cavernous compartments. Scale bar= 200 nm. e, Magnified inset from orange box in d, highlighting unknown densities within caverns. Scale bar= 60nm. f, Magnified inset from pink box in d, highlighting ordered peripheries. Scale bar= 60nm. g, Line profile of features in f, denoting regular spacing in ordered layer structure.

In addition to the yarn ball structures observed in CPEB3-GFP associated MVBs, lamellae from CPEB3 expressing cells also contained uniquely shaped, cavernous compartments (Figure 5a). These compartments were layered, but distinct from onion-like concentric lipid droplets (LDs); their layers were nearly twice the diameter of other reported striations36. The structures could also be categorized by size. A few of the compartments were less than ~ 0.5 μM in diameter and displayed ordered spiraled shells that entwined toward their interior (Figure 5a). The outer layers of the compartments displayed regular periodic structures. The components of these regularly spaced arrays were seen to twist toward the center of each compartment, blending into less distinguishable features (Figure 5b). Notably, the smaller compartments often contained cavernous spaces encasing poorly delineated densities (Figure 5c). We also observed ordered assemblies that formed large cavernous structures measuring up to 1 μM in diameter in surveyed lamellae (Figure 5d). Line profiles across layers of the cavernous compartment borders showed regular spacings, appearing to correspond to layered structures (Figure 5e, 5f). These characteristics were partially reminiscent of cholesteryl-ester LDs seen in mitotically arrested HeLa cells37, but no definitive assignment could be made for these organelles.

Persistent, exogenous expression of CPEB3 triggers cellular stress

Features observed in cells expressing exogenous CPEB3-GFP suggested a change in the physiological state of the cell. We therefore asked whether persistent exogenous expression of CPEB3-GFP could cause distress in U87 cells. We performed viability assays simultaneously staining for the apoptotic marker, Annexin and 7-amino-actinomycin D, to account for necrotic cells. Using flow cytometry, we found that after 24 hours of expression, approximately 13% of WT expressing cells were apoptotic, whereas cells expressing CPEB3ΔAC-GFP were closer to GFP control wells with 7% and 5% of cells staining positive for apoptotic marker, respectively (Supplementary Figure 13a). To evaluate the molecular sequelae associated with this cellular response, we analyzed transcriptional profiles of HT22 hippocampal neurons expressing WT CPEB3-GFP, CPEB3ΔAC-GFP, GFP and untreated cells. Based on normalized fold changes compared against both control samples, cells expressing CPEB3-GFP contained elevated transcripts of a variety of developmental and disease-associated genes (Supplementary Figure 13b). To specifically probe the role of the CPEB3 AC, we performed a cross comparison of normalized fold changes in WT and ΔAC CPEB3-expressing cells (Supplementary Figure 13b), identifying genes that were unique to WT cells. Here, we found that the majority of gene targets were involved in immune response (Supplementary Figure 13b, Supplementary Data 1-4); this included differentially expressed transcripts that encoded for guanylate-binding proteins (GBPs) functionally involved in pathogen protection responses38.38 These transcript changes and associated pathways indicate a cellular state of alert that is heightened in CPEB3-expressing cells, and to a lesser extent in the absence of the hCPEB3AC.

Discussion:

CPEB3, a member of the cytoplasmic polyadenylation family of proteins, binds mRNA transcripts to activate or repress protein synthesis39,40. This process was hypothesized to be regulated by its prion-like self-assembly4, although the atomic structure of prion or amyloid-like assemblies in cells by CPEB3 remained unwitnessed. We find an amyloid fibril structure of human CPEB3 PRD1 that supports the hypothesis that CPEB3 forms amyloids21. The ordered core of fibrils formed by this segment, hCPEB3AC, is composed of a single asymmetric protofilament with parallel, in register strands. However, while the overall architecture of hCPEB3AC resembles that of a canonical amyloid structure, it contains features that may decrease its stability, including buried polar residues and solvent channels. The ready assembly of these fibrils is a potential mechanism for modulating translational regulation by CPEB3, however, we note that reparteed disassembly and re-assembly of fibrils remains unexplored.

The amino terminal domains of many CPEB proteins are identified as prion-like in part due to their low-complexity sequences and their high number of uncharged polar residues4,6,41. In agreement with our data, experiments have predicted that the rigid core of mouse PRD1 assemblies spans residues E124-H145, and is divided into three main β-strands22. This is similar to the architecture of hCPEB3AC, which contains the largest hydrophobic pockets split between four β-sheets (Figure 1, Supplementary Figure 8b). This is unsurprising, since indeed the sequences of mouse and human CPEB3 PRD1s are highly similar and are identical within the hCPEB3AC (Figure 1a). However, the fibrils formed by mouse CPEB3 PRD1 reportedly contained a robust and proteinase K-resistant core22, indicating their relatively greater sturdiness compared to hCPEB3AC. This could be in part due to our construct containing the entire PRD1, including the proline and glutamine rich segments which are likely key contributors to the relatively labile nature of its fold. Other features that may contribute to the lability of hCPEB3AC include its buried charged residues (E120, D121), its four prolines, buried solvent channels, and its highly kinked and warped layers. These features could influence the regulated assembly of amyloid-like hCPEB3AC structures in neurons alongside other post-translational modifications (PTMs) involved in CPEB3 regulation in cells15,16,18. Their relevance is supported in our double point mutant studies, where ablation of these sites altered localization of CPEB3 aggregates in cells (Figure 2).

The physiological relevance of hCPEB3AC is underscored by the fact that translational regulation by CPEB3 is ablated in cells when it lacks its AC. Although the structures of amyloid fibrils reconstituted in vitro are known to be distinct from those isolated from disease tissue42–46, the relevance of hCPEB3AC to physiological CPEB3 function remains supported by several lines of evidence. These include 1) the role of its AC sequence in localization to puncta in cells; 2) the fact that point mutations ablating charges in hCPEB3AC alter CPEB3 distribution in cells; 3) cellular stress and loss of viability induced by wild-type CPEB3 overproduction in cells is absent in those lacking CPEB3AC; and most importantly, 4) that deletion of hCPEB3AC eliminates its ability to repress or activate mRNA targets, highlighting its role in translational activation by CPEB9,10 (Figure 4).

Finally, by visualizing neuronal subregions harboring hCPEB3, we begin to define the ultra-structures associated its amyloid-like state. These structures include MVBs with yarn-like fibrillar inclusions and a variety of intralumenal vesicles, morphologically similar to early-stage melanosomes containing Pmel1728, a functional amyloid glycoprotein involved in melanin pigmentation. Lamellae in hCPEB3 expressing cells also showed distinctive compartments varying in size; all had cavernous interiors that occasionally contained unidentified densities. Many of these compartments were large enough to preclude our full mapping of their exterior, making it difficult to discern whether the caverns in these compartments were fully enclosed, or open to the cytoplasmic environment. These compartments were present in a majority of U87 cells expressing hCPEB3 and might be associated with a stress response, akin to the lipidic structures reported in stressed yeast36, HeLa cells37or potentially associated with previously reported phase separation. This is consistent with our finding that prolonged exogenous expression of hCPEB3 reduces cell viability and alters transcriptional profiles to elicit immune responses. Importantly, these deleterious effects of hCPEB3 overexpression were less evident in cells expressing CPEB3ΔAC-GFP, indicating that hCPEB3AC is a defining feature of hCPEB3 associated with cellular stress.

Overall, hCPEB3AC appears to be a double edged sword that requires regulation in cells to avoid potential pathology. In fact, our collective observations of CPEB3 support a model by which the amyloid core of CPEB3 is an essential liability, a segment required for CPEB3 function but also associated with CPEB3-induced cellular stress. The localization of CPEB3 to p-bodies is sensitive to perturbations of hCPEB3AC and in its absence, CPEB3 localizes to stress granules. Based on these observations, hCPEB3AC may act as a regulatory element or may itself be subject to post-translational modifications such as SUMOylation18 and ubiquitination15. Perhaps regulation of hCPEB3AC in turn dictates the transition of CPEB3 into and out of its prion or amyloid-like state to limit its formation of large fibrillar inclusion bodies, as observed for pathogenic protein aggregates35,47.

Limitations of this study

The structural data we present are drawn primarily from recombinant constructs encoding only human CPEB31−217, corresponding to the first CPEB3 prion-like domain10. This segment forms fibrils at pH 4.5, a condition that is distinct from the pH of the cell. In addition, our cellular experiments rely on exogenous expression of CPEB3-GFP, rather than endogenously tagged CPEB3 expressed at baseline levels. Further work is needed to fully understand the role of native human CPEB3 in neurons, and to further characterize structural changes occurring as it transitions from basal to its stimulated states. While we found that over time, cells expressing CPEB3-GFP grew large puncta, these same cells suffered in viability after prolonged expression of the protein, indicating a degree of toxicity elicited by overexpression of CPEB3. Thus, our experiments highlight the need for investigation into the regulatory mechanisms that govern the CPEB3 amyloid state, and its aggregation and localization in cells.

Resource Availability

Lead Contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jose A. Rodriguez (jrodriguez@mbi.ucla.edu)

Materials Availability

All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement

Data and Code Availability

  • The coordinates of CPEB3-AC have been deposited in the PDB under accession code 8SPA and the map file in the EMDB with accession code EMD-40677 and are publicly available as of the date of publication. Accession codes are also listed in the key resources table. The tomograms of U87 cells expressing CPEB3-GFP are publicly available as of the date of publication under 10.5281/zenodo.15288496.

  • This paper does not report original code.

  • Any additional information required to re-process the data reported in this paper is available from the lead contact upon request.

Key resources table.
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
anti-Dcp1a rabbit polyclonal AbCam cat#ab47811
anti-G3BP mouse monoclonal AbCam cat#ab56574
Bacterial and virus strains
Escherichia coli BL21 DE3 Thermo EC0114
Escherichia coli DH5-alpha Thermo EC0112
Biological samples
Chemicals, peptides, and recombinant proteins
NucBlue Thermo R37605
Critical commercial assays
Halt protease inhibitor cocktail Thermo 78438
ABClonal Stranded mRNA-seq Lib Prep kit AbClonal RK20301
Deposited data
CPEB3-AC structure This work 8SPA
CPEB3-AC map This work EMD-40677
Tomograms of U87 cells expressing CPEB3-GFP This work 10.5281/zenodo.15288496
Experimental models: Cell lines
HEK293 cells ATCC CRL-1573
Primary Hippocampal Neurons This work N/A
HT22 hippocampal neurons Millipore Sigma SCC129
U87 glioblastoma cells ATCC HTB-14
Experimental models: Organisms/strains
Oligonucleotides
Primer for sequencing CPEB3 plasmids: 5′ – TAATACGACTCACTATAG – 3′ This work N/A
Recombinant DNA
CPEB3 1–217 in pET—24(+) vector Twist N/A
CPEB3-GFP Twist N/A
Software and algorithms
Relion v3.1 Scheres et al.49 https://relion.readthedocs.io/en/release-5.0/#
Bcl2fastq v2.19.1.403 Illumina N/A
PyRosetta Ref2015 Chaudhury et al.54 https://www.pyrosetta.org/
NanoScope Analysis v2.0 Bruker http://nanoscaleworld.brukeraxs.com/nanoscaleworld/media/p/775.aspx
EPU v2.8 Thermo N/A
ChimeraX v1.9 UCSF https://www.cgl.ucsf.edu/chimerax/
Coot v1.21 Emsley et al.52 https://www2.mrclmb.cam.ac.uk/personal/pemsley/coot/
Other

STAR METHODS

EXPERIMENTAL MODEL AND STUDY PARTICIPANTS

Microbe strains

E. coli strain DH5 alpha was used for mini and maxi preps, while E. coli BL21 gold for protein production. Both were cultured in luria broth unless otherwise noted.

Mammalian cell lines

HT22 hippocampal neurons and U87 glioblastomas were cultured in Dulbecco’s modified Eagle’s medium with 10% Fetal Bovine Serum (ThermoFisher) and 1% penicillin/streptomycin (ThermoFisher) in a tissue-culture incubator at 37°C and 5% CO2.

METHOD DETAILS

Construct design

Design of recombinant CPEB3 segment included previously reported residues critical for aggregate formation and prion-like behavior in cells10. CPEB3 residues 1–217 were inserted into pET—24(+) vector from TWIST biosciences. Sequences were verified via DNA sequencing (Genewiz).

Protein expression and purification

Recombinant CPEB31–217 was expressed in Escherichia coli BL21 GOLD cells. Briefly, cells were grown in LB media with 50 ug/ml kanamycin at 37° C to an OD600 of 0.6–0.8. 1 mM isopropyl B-D-1-thiogalactopyranoside (IPTG) was added for protein expression and cells were cultured an additional 6 hrs at 37° C. Cells were harvested and stored at −20° C until purification. Cell lysates were resuspended in lysis buffer containing 10 mM Tris, 1 mM EDTA at pH 8.2 and supplemented with 1% halt protease inhibitor cocktail (Thermo Scientific), 1% homemade Benzonase and subsequently lysed using 6 consecutive freeze-thaw cycles in liquid nitrogen. Cell lysates were centrifuged (12,000gs for 30min) and pellet was resuspended in 6M guanidinium hydrochloride (Gdn-HCl), 50mM Tris-Base, 25mM imidazole at pH 8 and left gently shaking on ice overnight. Lysates were centrifuged (3,000gs for 30 min) and supernatant was filtered and loaded onto an equilibrated HisTrap HP column (GE) using NGC (Biorad). The HisTrap was pre-equilibrated with 6M Gdn-HCl, 50mM Tris-Base and 25 mM imidazole. Protein was eluted with gradient protocol containing 6M Gdn-HCl, 50mM Tris-Base and 500 mM imidazole. Eluted protein was flash frozen and stored at −80° C until further purification. Further purification was executed with RP-HPLC, using an Interchim puriFlash® 4125 Preparative Liquid Chromatography System equipped with an Interchim PT-15C8-F0040 cartridge (C8,15 μm particle size). The eluted protein fractions were defrosted from −80°C and pooled. The pooled sample was then diluted to 1.8 mL with a dilution buffer consisting of 6 M Gdn-HCl, 50 μM NaH2PO4, 10 μM Tris, and 20 μM imidazole. Before injection the 2-mL sample loop was washed with the above dilution buffer to maintain high concentrations of guanidine to minimize protein aggregation. [A] consisted of a 99 to 1 water to acetonitrile solution with 15 mM NH4OH added as a buffer. [B] consisted of a 40 to 60 water to acetonitrile solution with 15 mM NH4OH. Flow rate was set at 40 mL/min. Before injection, the system was equilibrated to 100% [A]. The protein sample was loaded onto the loop and injected. Three wavelengths were used to monitor the purification: 214 nm (black), 280 nm (orange), and 254 nm (light blue). The gradient was held at 100% [A] for 5 minutes then a gradual increase to 100% [B] was executed over a span of 25 minutes (Δ5% per minute). The target protein started eluting at 16 minutes.

Fibril preparation and negative stain TEM

Lyophilized protein powder was resuspended in water at 1.2 mg/mL concentration, aliquoted and immediately flash frozen and stored at −20°C until further use. Various buffers containing high concentrations of urea and guanidine were initially screened for fibril formation to attempt to control clumping and aggregation. Since these aggregates were heterogenous and sporadic, we instead chose to pursue conditions that yielded homogeneous aggregates by performing 96well screens ranging in salt concentrations and pH, but without denaturants. The optimized fibril growth condition was incubation in 125mM NaCl, 50mM Tris-Base, 10mM K2PO4 and 5mM glutamic acid ~pH 4.5 and left shaking overnight on an acoustic resonant shaker at 37°C. Fibrils were collected by harvesting and pooling solution from wells and immediately prepared for subsequent experiments. Negative-stain transmission EM samples were prepped by applying 3 μl of fibril solution to glow-discharged 300 mesh carbon-coated formvar support films mounted on Cu grids (Ted Pella). The samples were wicked, washed briefly with water, stained with 2% uranyl acetate for 90 seconds and wicked again, allowing to air dry for 3 minutes. Grids were imaged on a T12 (FEI) electron microscope.

Atomic force microscopy of CPEB3 fibrils

CPEB3 fibrils grown overnight as described above were collected and a 15 μl aliquot of the supernatant was deposited onto freshly cleaved mica, incubated for 10 min, rinsed with 200 μl of water, and dried by nitrogen. Images were taken on a Bruker Dimension Icon microscope (UCLA CNSI Nano & Pico Characterization Laboratory) in PeakForce Tapping mode with a Scanasyst-Air-HPI probe. Images were flattened and analyzed using NanoScope Analysis 2.0 software (Bruker); their color scales were adjusted in the display image as indicated.

Single particle cryo-EM sample preparation and data collection

Freshly harvested fibril solution was diluted 5 fold with buffer containing 100mM NaCl, 10mM Tris-Base, 5mM DTT and 0.25% glycerol. 1.6 μL of diluted fibril solution was applied to each side of a glow-discharged Ultrathin carbon on Quantifoil 1.2/1.3 300 mesh on Au grid (Ted Pella) and plunge frozen into liquid ethane using a Vitrobot Mark IV (FEI) set at 100% humidity, 4°C with a blot force of −1 and blot time of 1.5 seconds. Data were collected on a Titan Krios G3i microscope with a K3 direct detection camera (Gatan) operated at an accelerating voltage of 300 keV and a 20eV slit width (BioQuantum). Automated data acquisition was performed using EPU 2.8 software (Thermo Scientific). Images were acquired with a nominal magnified pixel size of 0.86 Å/pixel, a total of 40 frames with a dose of 1.3 electrons per Å2 per frame resulting in a total dose of 52 electrons per Å2.

Data processing and helical reconstruction

CTF estimation were performed with CTFFIND 4.1.848. Drift-correction and dose-weighting were performed using MotionCor2 implemented in RELION 3.149. Particles were picked with the automatic particle picking software crYOLO50. All subsequent image processing and helical reconstruction were performed in RELION as previously described.42,51 Briefly, fibril segments were initially extracted with a 90% overlap into 512 pixel boxes binned by 2 (1.72 A/pix) and subjected to reference-free 2D classification using a T=2 regularization parameter. Segments belonging to suboptimal 2D averages were discarded and homogenous subsets were selected for further processing. Upon identification of a rapidly twisting species, a smaller box size was chosen. All segments were then extracted with a 90% overlap into 384 pixel boxes for a total of 2,410,032 segments. Segments were split into 10 groups and several rounds of reference free 2D classification were performed to weed out suboptimal segments. Homogenous subsets from each were regrouped and reference free 2D classification were iteratively run decreasing psi_step and offset_step from 8 to 1. After the majority of suboptimal particles had been discarded an additional round of classification were performed with the tau regularization parameter set to T= 8. Only segments contributing to averages showing clear 4.8 Å signal in corresponding 2D FFTs were selected for subsequent 3D processing, resulting in 119,372 segments. Using both the 512 pixel box and 384 pixel box an initial helical pitch of 536 Å and helical twist of −3.22° were estimated. Starting with these estimates a 3D reference was reconstructed de-novo with 384 pixel 2D averages showing clear β-strand separation along the helical axis. 3D manual refinements were performed using a 30 Å low-pass filtered initial model, K=3 and with manual control of tau_fudge and healpix to reach a resolution of ~ 5Å. Segments contributing to a homogeneous class as defined by stable helicity and separation of β-strands resulted in a final subset of 40,329 segments. Again, a manual 3D refinement was performed on selected segments leading to a reconstruction of 3.5 Å. Several 3D auto-refinements using a 7Å low-pass filtered map from the final manual refinement were run with optimization of helical parameters leading to an estimated helical rise of 4.91 Å and a helical twist of −3.32°. This map was then used for per-particle CTF estimation and a 3D auto-refinement was repeated. The nominal pixel size was adjusted from 0.86 Å to 0.879 Å, resulting in an expected helical rise of 4.8 Å. Post-processing of the map with an extended initial mask of 3 pixels and soft edge of 10 pixels was followed by clipping and centering the map using clip.com. Auto-sharpening using phenix.auto_sharpen at the resolution cutoff indicated by the half-map GSFSC led to a final overall resolution of 3.0 Å. The atomic model was built into the refined map using COOT52. We performed automated structure refinement using phenix.real_space_refine (Phenix 1.2)53.

Sequence profiling

Sequences were threaded onto a hand-modeled backbone trace built into the fibril core density using a custom python script utilizing the PyRosetta54 software package and a sliding window approach. For each window, the experimentally expressed sequence was threaded onto a polyalanine backbone then energy minimized with the PyRosetta FastRelax with cryo-EM density function. FastRelax used the Ref201555 energy function with a modified fa_elec weight to 1.5 and elec_dens_fast weight of 25. Each sequence window was energy minimized in triplicate and the resulting scores were averaged. Symmetry was applied to pose objects to increase speed of computation.

Energetic calculations

Solvation free energy calculations were performed as recently described23. Briefly, the solvent accessible surface area (SASA) for each atom in a residue was determined (folded state). Next, the SASA for each atom of a residue was determined in the absence of the other residues (reference state), and the difference between both states was calculated (SASARef – SASAFold). This value was then multiplied by the Atomic Solvation Parameter (ASP) specific to each atom, as determined previously by Eisenberg et al56. An entropic term is also included to take into consideration the degrees of freedom lost in going from a disordered to ordered state57. The energies of all atoms were then summed to generate the solvation energy for each structure. Difference energy maps were generated by subtracting solvation free energies pairwise for each atom in the two structures being compared.

Analysis of SASA per chain

Solvent accessible surface area was calculated using a 5-layer model of the CPEB3AC fibril structure using the rolling ball method.

Molecular dynamics simulations

Molecular dynamics simulations were performed with the GROMACS58 software package (version 2022.2) using the CHARMM2759 all-atom forcefield. Simulations were carried out with a 5-layer CPEB fibril under varying charge states to simulate fibril dynamics at pHs 3, 5, and 7. The N- and C-termini of the fibril were capped with an acetyl and N-methyl amide group, respectively. In each case, the fibril was placed in a cubic box, solvated with SPC/E three-point water molecules and added counter ions. The system was energy minimized, then temperature and pressure equilibrated for 100 ps. Final simulations were executed for 200 ns.

Thioflavin T-binding and dissolution assays

Protein was resuspended in fibril formation buffer as described previous at 25 μM concentration with equal parts ThT. Solution was pipetted into a 96-well well plate with optical bottom (Sigma-Aldrich) and incubated at 37°C with continuous shaking. ThT fluorescence was measure with an excitation filter of 440 nm and emission filter of 480nm using a Varioskan plate reader (ThermoFisher). Aggregation curves were generated from triplicate, n=3 wells. Dissolution assays were started after 18 hours of fibril formation. Because fibrils were not able to be resuspended in different buffers due to their liability, a 96-well plate was prepared by three-fold dilution of fibril-containing solutions into each buffer. The buffers used for dissolution experiments contained 100mM NaCl, 50mM K2HPO4/KH2PO4 with addition of NaOH for pH adjustment. Normalization of ThT intensity was performed to account for variations across experiments and reduction of signal when diluting samples for dissolution assays.

Cell culture for live imaging

Cells were plated and cultured on 12-mm glass coverslips coated with poly–L-lysine (Sigma) and Laminin 50 uG (Sigma) in 6-well cell-culture plates. Cells were plated at 70% confluency overnight and transfected using Lipofectamine 3000 kit (ThermoFisher) for an 8 hr incubation. Cells were harvested and/or imaged at 24 hours post transfection for all experiments. Live fluorescent images were acquired on an EVOS M7000 (ThermoFisher) on a 40X objective.

Immunofluorescence and puncta analysis

Cells were fixed in 2% paraformaldehyde at 4°C for 10 minutes and permeabilized using 0.5% PBS-Triton X-100 for 10 minutes. Cells were subsequently washed with PBS-T and blocked with 2% BSA, 0.5%FSG, and PBS-T solution for 1hr at room temperature. Cells were incubated with primary antibodies diluted in blocking solution for approximately 2 hours. Cells were washed with PBS-T three times before beginning incubation with secondary antibodies and washed with PBS-T. Coverslips were mounted using Prolong Glass Antifade Mountant (ThermoFisher) and allowed to dry for 72 hours. Fluorescent images were acquired on a Leica confocal SP8-STED/FLIM/FCS on a 60X water immersion objective. Puncta were manually counted and distances were manually calculated by averaging X and Y for each puncta in GFP channels. Image analyses were performed in FIJI (ImageJ).

Luciferase assays

HEK293 cells were plated at 50% confluency overnight and transfected using Lipofectamine 3000 kit (ThermoFisher) with ~0.5 μg of CPEB3 DNA, 0.5 μg of Renilla luciferase appended with GluA2 3′ UTR or SUMO2 3’UTR, and 0.5 μg of Firefly luciferase60.

18/24 hr after transfection, cells were lysed with 100 μl of buffer for dual luciferase assay (Promega). 20 μl of the lysates were used for the quantification of Firefly and Renilla Luciferase activity using a Luminometer (GloMax, Promega).

Hippocampal neurons cultured for 9–10 days in Neurobasal medium with B27 supplement (Invitrogen) at a cell density of 30 000–40 000/cm2 were cotransfected (Lipofectamine LTX, LifeScience) for 3 h with ~0.5 μg of CPEB3 DNA, 0.5 μg of Renilla luciferase appended with GluA2 3′ UTR, and 0.5 μg of Firefly luciferase. We used glycine to stimulate the NMDA receptors selectively, a protocol that mimics LTP induction in cultured neurons. Chem-LTP was induced as described previously61. Briefly, neuronal cultures were transferred from Neurobasal growth medium to extracellular solution (ECS) containing: 150 mM NaCl, 2 mM CaCl 2 , 5 mM KCl, 10 mM HEPES(pH 7.4), 30 mM glucose, 0.5mM TTX, 20mM bicuculline methiodide. The transfected neurons were stimulated with 200μM glycine for 3 min and then washed for 30 minutes before lysis in 100 μl of buffer for dual luciferase assay (Promega). 20 μl of the lysates were used for the quantification of Firefly and Renilla Luciferase activity using a Luminometer (GloMax, Promega). The ratio between Renilla and Firefly is calculated for each experimental condition.

Cryo-ET sample preparation and cryo-FIB milling

Ultrathin carbon (2 nm) Quantifoil 2/1 300 mesh on Au grids or Quantifoil 2/2 300 mesh on silicon dioxide grids were glow discharged for 30 seconds and subsequently sterilized with 70% ethanol and coated with poly-L-lysine (Sigma) and Laminin 50 uG (Sigma). U87 cells were seeded and cultured as described previously in cell culture section. Neurons were transfected as previously described in cell culture section and samples were selected for vitrification by screening on an EVOS M7000 (ThermoFisher) with a 20X objective to check for CPEB3-GFP expression and distribution on grids. Selected samples were plunge frozen into liquid ethane using a Vitrobot Mark IV (FEI) set at 100% humidity, 37°C with a blot force of 10 and blot time of 15 seconds after 24 hours of expression. Grids were mounted on cryo-FIB autogrids and were loaded onto an Aquilos II cryogenic FIBSEM instrument for cryo-FIB milling (ThermoFisher). MAPS software (ThermoFischer) was used to aid in correlation using a combination of room temperature fluorescence images and images acquired using the integrated fluorescence light microscope (iFLM) in the FIBSEM and for acquisition of a SEM medium magnification montage. Fluorescent and SEM atlases were overlaid for correlation and selection of CPEB3-GFP expressing cells. Cells were selected for milling based on puncta phenotypes and overall placement on grid squares. Grids were coated using a gas injection system with an organometallic platinum layer of ~7–10 nm and then sputter coated with platinum for ~30 seconds. Briefly, cryoFIB milling was performed using a stepwise decreasing current (500 pA – 30 pA), manually as described previously62, and automatically using AutoTEM (ThermoFischer) with milling angles ranging from 8° – 15°. SEM imaging was used to monitor milling progress throughout. Final lamellae thickness ranged from 150 nm – 250 nm. Final polished lamellae were sputter coated for 15 seconds and the iFLM was used to acquire GFP fluorescence z-stacks to aid in correlation during data collection.

Cryo-ET data collection and tomographic reconstruction

Data were collected on a Titan Krios G3i microscope with a K3 direct detection camera (Gatan) operated at an accelerating voltage of 300 keV and a 20eV slit width (BioQuantum) or with a Titan Krios G4 with a Falcon4EC (ThermoFisher) and a 10eV slit width. Data were also collected on a Talos Arctica with a K2 Summit direct detection camera (Gatan) operating at an accelerating voltage of 200 keV and 20eV slit width (BioQuantum). For lamellae with fluorescent data, medium magnification montages were acquired using SerialEM and overlaid with GFP maximum intensity projections acquired on iFLM using MAPS. Tilt series acquisition was selected for based on signal presence and intensity on lamellae. Automated data acquisition was performed using SerialEM software at a nominal magnified pixel size of 3.64 Å/pix or 4.27 Å/pix. Dose symmetric tilt series were acquired between −60° to +60° with either 2° or 3° steps. On average, 7 frames were recorded for each image for a total electron dose of ~ 100 – 120 e−/Å2 and a defocus target of −5 to −7 μM. Frames were aligned using MotionCor263 and automatically reconstructed in EMAN264. Tomograms were screened and selected for based on their contents and quality and subsequently reprocessed as follows. Tilt series were aligned using fiducial-less patch tracking and reconstructed by weighted back projection in IMOD65 binned by two, with frames containing obstructions such as ice contaminations manually removed before alignment. A CTF-based deconvolution filter was applied to each tomogram for visualization purposes66. Processed tomograms are available from DOI: 10.5281/zenodo.15288496

Analysis of gene expression

Samples for RNA expression were prepared as follows. HT22 cells alone as well as those expressing CPEB3 constructs were cultured as previously described, then RNA was purified using Qiagen RNeasy Mini Kit. Libraries for RNA-Seq were prepared with ABClonal Stranded mRNA-seq Lib Prep kit. Sequencing was performed on Illumina HiSeq 3000. Data quality check was performed on Illumina SAV. Demultiplexing was performed using the Illumina Bcl2fastq v2.19.1.403 software, with the Partek flow being used for data analysis. Transcript alignment was performed using STAR with reference genome mouse mm39. Ensembl Transcripts release mm39 - Ensembl Transcripts release 107 was used for gene feature annotation. Counts per Million (CPM) normalization of transcripts was followed by adding 0.0001. Partek GSA (version 3.5) was used to determine differentially expressed genes between sample set comparisons. Different P-value thresholds were used to filter for significantly differentially expressed genes. Gene Ontology enrichment was determined by ShinyGO 0.77.

QUANTIFICATION AND STATISTICAL ANALYSIS

Data are expressed as mean or median ± standard error of the mean (SEM) and graphed as scatter plots. For Violin Plots, data are expressed as median ± IQR (interquartile between 25th and 75th percentile). The GraphPad Prism 9 software was used for the statistical analysis. All data were tested for normal distribution using the Shapiro–Wilk normality test. For >2 groups, the results were analyzed by one-way or two-way ANOVA followed by Tukey’s multiple comparisons test. Additional information on the tests including the number of repeats and (Avg) ± SE are stated in figure legends. The refinement statistics and other parameters associated with Cryo-EM data collection are summarized in Table 1.

Table 1. Cryo-EM data collection, refinement and validation statistics.

CPEB3AC
Data collection and processing
Magnification 105,000
Voltage (kV) 300
Electron exposure (e–/Å2) 52
Defocus range (μm) 1–3
Pixel size (Å) 0.86
Symmetry imposed C1
Helical rise (Å) 4.8
Helical twist (°) −3.32
Initial particle images (no.) 2,410,032
Final particle images (no.) 40,329
Map resolution (Å) 3.0
FSC threshold 0.143
Map resolution range (Å) 200–3.0
Refinement
Initial model used (PDB code) de novo
Model resolution (Å) FSC threshold 3
Model resolution range (Å) 200–3.0
Map sharpening B factor (Å2) − 100.35
Model composition
Non-hydrogen atoms 374
Protein residues 49
Ligands 0
Protein
R.m.s. deviations
Bond lengths (Å) 0.006
Bond angles (°) 0.753
Validation
MolProbity score 1.79
Clashscore 9.26
Ramachandran plot
Favored (%) 95.74
Allowed (%) 4.26

Supplementary Material

1

Highlights:

  • Human CPEB31–217 self-assembles into labile amyloid fibrils in vitro

  • The cryo-EM structure of hCPEB31–217 displays a proline and charge-rich amyloid core

  • Removing the amyloid core from hCPEB3 abolishes its protein synthesis regulation

  • Cryo-ET of CPEB3-GFP in cells shows multi lamellar compartments and bundled filaments

Acknowledgments:

We thank Peng Ge (UCLA) for helpful discussions during cryoEM data processing, assistance during data acquisition, Duilio Cascio (UCLA) for assistance during model building and refinement, Corey Hecksel (SLAC) for assistance during data acquisition, Ambarneil Saha for assistance with RNA seq analysis, and Po-Tao Chen for assistance in culturing primary neurons. Part of this work was performed at the Stanford-SLAC Cryo-EM Center (S2C2), which is supported by the National Institutes of Health Common Fund Transformative High-Resolution Cryo-Electron Microscopy program (U24GM1295410). We are grateful to Wong Hoi Hui of the Electron Imaging Center for NanoMachines (EICN) for help and advice during cryoEM screening and sample preparation, and the staff of the UCLA CNSI Nano & Pico Characterization Laboratory, and thank Chensong Zhang and Jae Yang for assistance during cryo-ET data collection. Part of this work was performed at the Midwest Center for Cryo-ET (MCCET) and the Cryo-EM Research Center located in the Department of Biochemistry at the University of Wisconsin-Madison, supported by the NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program (U24 GM139168). This work was principally supported by NIH-NIGMS Grant R35 GM128867. M.D.F is supported by Eugene V. Cota-Robles Fellowship, Ruth L. Kirschstein NRSA GM007185, Whitcome Pre-Doctoral Fellowship, Audree V. Fowler Fellowship and a National Science Foundation Graduate Research Fellowship. J.A.R. is supported as a Pew Scholar, a Beckman Young Investigator and a Packard Fellow. This work was performed as part of STROBE, an NSF Science and Technology Center through Grant DMR-1548924, and by DOE Grant DE-FC02-02ER63421.

Footnotes

Declaration of Interests:

JAR is an equity stake holder of MedStruc Inc. The other authors declare no competing interests.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Prusiner SB (1982) Novel Proteinaceous Infectious Particles Cause Scrapie. Science 216, 136–144. [DOI] [PubMed] [Google Scholar]
  • 2.Shorter J & Lindquist S (2005) Prions as adaptive conduits of memory and inheritance. Nature Reviews Genetics 6, 435–450. [DOI] [PubMed] [Google Scholar]
  • 3.Eisenberg D & Jucker M (2012) The amyloid state of proteins in human diseases. Cell 148, 1188–1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rayman JB & Kandel ER (2017) Functional Prions in the Brain. Cold Spring Harb. Perspect. Biol. 9, a023671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.McGaugh JL (2000) Memory - A century of consolidation. Science 287, 248–251. [DOI] [PubMed] [Google Scholar]
  • 6.Si K, Lindquist S & Kandel ER (2003) A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties. Cell 115, 879–891. [DOI] [PubMed] [Google Scholar]
  • 7.Khan MR et al. (2015) Amyloidogenic Oligomerization Transforms Drosophila Orb2 from a Translation Repressor to an Activator. Cell 163, 1468–1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Keleman K, Krüttner S, Alenius M & Dickson BJ (2007) Function of the Drosophila CPEB protein Orb2 in long-term courtship memory. Nat Neurosci 10, 1587–93. [DOI] [PubMed] [Google Scholar]
  • 9.Fioriti L et al. (2015) The Persistence of Hippocampal-Based Memory Requires Protein Synthesis Mediated by the Prion-like Protein CPEB3. Neuron 86, 1433–1448. [DOI] [PubMed] [Google Scholar]
  • 10.Stephan JS et al. (2015) The CPEB3 Protein Is a Functional Prion that Interacts with the Actin Cytoskeleton. Cell Rep. 11, 1772–1785. [DOI] [PubMed] [Google Scholar]
  • 11.Hervas R et al. (2020) Cryo-EM structure of a neuronal functional amyloid implicated in memory persistence in Drosophila. Science 367, 1230–1234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Duran-Arqué B et al. (2022) Comparative analyses of vertebrate CPEB proteins define two subfamilies with coordinated yet distinct functions in post-transcriptional gene regulation. Genome Biol. 23, 192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Vogler C et al. (2009) CPEB3 is associated with human episodic memory. Front. Behav. Neurosci. 3, 3–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chao HW et al. (2013) Deletion of CPEB3 enhances hippocampus-dependent memory via increasing expressions of PSD95 and NMDA receptors. J. Neurosci. 33, 17008–17022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pavlopoulos E et al. (2011) Neuralized1 activates CPEB3: A function for nonproteolytic ubiquitin in synaptic plasticity and memory storage. Cell 147, 1369–1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ford L, Ling E, Kandel ER & Fioriti L (2019) CPEB3 inhibits translation of mRNA targets by localizing them to P bodies. 116, 18078–18087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chen CC et al. (2024) Inhibition of Cpeb3 ribozyme elevates CPEB3 protein expression and polyadenylation of its target mRNAs and enhances object location memory. E life 13, e90116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Drisaldi B et al. (2015) SUMOylation Is an Inhibitory Constraint that Regulates the Prionlike Aggregation and Activity of CPEB3. Cell Rep. 11, 1694–1702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fiumara F, Fioriti L, Kandel ER & Hendrickson WA (2010) Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins. Cell 143, 1121–1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ramírez De Mingo D, Pantoja-Uceda D, Hervás R, Carrión-Vázquez M & Laurents DV (2022) Conformational dynamics in the disordered region of human CPEB3 linked to memory consolidation. BMC Biol. 20, 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Gu X et al. (2020) Exploring the F-actin/CPEB3 interaction and its possible role in the molecular mechanism of long-term memory. Proc. Natl. Acad. Sci. U. S. A. 117, 22128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Reselammal DS et al. (2021) Mapping the Fibril Core of the Prion Subdomain of the Mammalian CPEB3 that is Involved in Long Term Memory Retention. J. Mol. Biol. 433, 167084. [DOI] [PubMed] [Google Scholar]
  • 23.Sawaya MR, Hughes MP, Rodriguez JA, Riek R & Eisenberg DS (2021) The expanding amyloid family: Structure, stability, function, and pathogenesis. Cell 184, 4857–4873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Murray DT et al. (2017) Structure of FUS Protein Fibrils and Its Relevance to Self-Assembly and Phase Separation of Low-Complexity Domains. Cell 171, 615–627.e16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wasmer C et al. (2008) Amyloid fibrils of the HET-s(218–289) prion form a β solenoid with a triangular hydrophobic core. Science 319, 1523–1526. [DOI] [PubMed] [Google Scholar]
  • 26.Lu J et al. (2020) CryoEM structure of the low-complexity domain of hnRNPA2 and its conversion to pathogenic amyloid. Nat Commun 11, 4090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.McGlinchey RP & Lee JC (2017) Reversing the Amyloid Trend: Mechanism of Fibril Assembly and Dissolution of the Repeat Domain from a Human Functional Amyloid. Isr. J. Chem. 57, 613–621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Maji SK et al. (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328–332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ramírez de Mingo D et al. (2023) Phase separation modulates the functional amyloid assembly of human CPEB3. Prog. Neurobiol. 231, 102540. [DOI] [PubMed] [Google Scholar]
  • 30.Protter DSW & Parker R (2016) Principles and Properties of Stress Granules. Trends Cell Biol. 26, 668–679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Drisaldi B et al. (2020) Cytoplasmic Polyadenylation Element Binding Proteins CPEB1 and CPEB3 Regulate the Translation of FosB and Are Required for Maintaining Addiction-Like Behaviors Induced by Cocaine. Front. Cell. Neurosci. 14, 207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hervás R et al. (2021) Divergent CPEB prion-like domains reveal different assembly mechanisms for a generic amyloid-like fold. BMC Biol. 19, 1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Huang WH, Chao HW, Tsai LY, Chung MH & Huang YS (2014) Elevated activation of CaMKIIα in the CPEB3-knockout hippocampus impairs a specific form of NMDAR-dependent synaptic depotentiation. Front. Cell. Neurosci. 8, 367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Jaafari N et al. (2013) SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor Surface Expression (ChemLTP) in Hippocampal Neurons. PLoS One 8, 52345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bäuerlein FJB et al. (2017) In Situ Architecture and Cellular Interactions of PolyQ Inclusions. Cell 171, 179–187. [DOI] [PubMed] [Google Scholar]
  • 36.Rogers S et al. (2022) Triglyceride lipolysis triggers liquid crystalline phases in lipid droplets and alters the LD proteome. J. Cell Biol. 221, e202205053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mahamid J et al. (2019) Liquid-crystalline phase transitions in lipid droplets are related to cellular states and specific organelle association. Proc. Natl. Acad. Sci. U. S. A. 116, 16866–16871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Vestal DJ & Jeyaratnam JA (2011) The Guanylate-Binding Proteins: Emerging Insights into the Biochemical Properties and Functions of This Family of Large Interferon-Induced Guanosine Triphosphatase. J. Interf. Cytokine Res. 31, 89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Richter JD (2007) CPEB: a life in translation. Trends Biochem. Sci. 32, 279–285. [DOI] [PubMed] [Google Scholar]
  • 40.Kozlov E, Shidlovskii YV, Gilmutdinov R, Schedl P & Zhukova M (2021) The role of CPEB family proteins in the nervous system function in the norm and pathology. Cell Biosci 11, 64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Raveendra BL et al. (2013) Characterization of prion-like conformational changes of the neuronal isoform of Aplysia CPEB. Nat. Struct. Mol. Biol. 20, 495–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Cao Q, Boyer DR, Sawaya MR, Ge P & Eisenberg DS (2019) Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat. Struct. Mol. Biol. Nat Struct Mol Biol 7, 619–627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Arseni D et al. (2022) Structure of pathological TDP-43 filaments from ALS with FTLD. Nature 601, 139–143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Glynn C et al. (2020) Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core. Nat. Struct. Mol. Biol. 27, 417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Manka SW et al. 2.7 Å cryo-EM structure of ex vivo RML prion fibrils. Nat. Commun 13, 4004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kraus A et al. (2021) High-resolution structure and strain comparison of infectious mammalian prions. Mol. Cell 81, 4540–4551. [DOI] [PubMed] [Google Scholar]
  • 47.Guo Q et al. (2018) In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment. Cell 172, 696–705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rohou A & Grigorieff N (2015) CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Scheres SHW (2020) Amyloid structure determination in RELION-3.1. Acta Crystallogr. D Struct Biol 76, 94–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Wagner T et al. (2019) SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2, 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Fitzpatrick AWP et al. (2017) Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature 547, 185–190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Emsley P, Lohkamp B, Scott WG & Cowtan K (2010) Biological Crystallography Features and development of Coot. Acta Crystallogr. D 66, 486–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Afonine PV et al. (2018) Real-space refinement in PHENIX for cryo-EM and crystallography. Res. Pap. Acta Cryst 74, 531–544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Chaudhury S, Lyskov S & Gray JJ (2010) PyRosetta: A script-based interface for implementing molecular modeling algorithms using Rosetta. Bioinformatics 26, 689–691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Alford RF et al. (2017) The Rosetta all-atom energy function for macromolecular modeling and design HHS Public Access. J Chem Theory Comput 13, 3031–3048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Eisenberg David, M DA. (1986) Solvation energy in protein folding and binding. Nature 319, 199–203. [DOI] [PubMed] [Google Scholar]
  • 57.Koehl P & Delarue M (1994) Application of a self-consistent mean field theory to predict protein side-chains conformation and estimate their conformational entropy. J. Mol. Biol. 239, 249–275. [DOI] [PubMed] [Google Scholar]
  • 58.Van Der Spoel D et al. (2005) GROMACS: Fast, flexible, and free. J. Comput. Chem. 26, 1701–1718. [DOI] [PubMed] [Google Scholar]
  • 59.Vanommeslaeghe K et al. (2010) CHARMM General Force Field (CGenFF): A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Cormier MJ & Kazuo H (1964) Studies on the bioluminescence of Renilla renoformis. Biochim. Biophys. Acta - Spec. Sect. Biophys. Subj. 88, 99–104. [PubMed] [Google Scholar]
  • 61.Jaafari N, Konopacki FA, Owen TF, Kantamneni S & Rubin P (2013) SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor Surface Expression (ChemLTP) in Hippocampal Neurons. PLoS One 8, 52345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Schaffer M et al. (2015) Cryo-focused Ion Beam Sample Preparation for Imaging Vitreous Cells by Cryo-electron Tomography. BIO-PROTOCOL 5, e1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Zheng SQ et al. (2017) MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 2017 144 14, 331–332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Marrs V et al. (2019) A complete data processing workflow for cryo-ET and subtomogram averaging. Nat. Methods 11, 1161–1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Kremer JR, Mastronarde DN & McIntosh JR (1996) Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116, 71–76. [DOI] [PubMed] [Google Scholar]
  • 66.Tegunov D & Cramer P (2019) Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 2019 1611 16, 1146–1152. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Data Availability Statement

  • The coordinates of CPEB3-AC have been deposited in the PDB under accession code 8SPA and the map file in the EMDB with accession code EMD-40677 and are publicly available as of the date of publication. Accession codes are also listed in the key resources table. The tomograms of U87 cells expressing CPEB3-GFP are publicly available as of the date of publication under 10.5281/zenodo.15288496.

  • This paper does not report original code.

  • Any additional information required to re-process the data reported in this paper is available from the lead contact upon request.

Key resources table.

REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
anti-Dcp1a rabbit polyclonal AbCam cat#ab47811
anti-G3BP mouse monoclonal AbCam cat#ab56574
Bacterial and virus strains
Escherichia coli BL21 DE3 Thermo EC0114
Escherichia coli DH5-alpha Thermo EC0112
Biological samples
Chemicals, peptides, and recombinant proteins
NucBlue Thermo R37605
Critical commercial assays
Halt protease inhibitor cocktail Thermo 78438
ABClonal Stranded mRNA-seq Lib Prep kit AbClonal RK20301
Deposited data
CPEB3-AC structure This work 8SPA
CPEB3-AC map This work EMD-40677
Tomograms of U87 cells expressing CPEB3-GFP This work 10.5281/zenodo.15288496
Experimental models: Cell lines
HEK293 cells ATCC CRL-1573
Primary Hippocampal Neurons This work N/A
HT22 hippocampal neurons Millipore Sigma SCC129
U87 glioblastoma cells ATCC HTB-14
Experimental models: Organisms/strains
Oligonucleotides
Primer for sequencing CPEB3 plasmids: 5′ – TAATACGACTCACTATAG – 3′ This work N/A
Recombinant DNA
CPEB3 1–217 in pET—24(+) vector Twist N/A
CPEB3-GFP Twist N/A
Software and algorithms
Relion v3.1 Scheres et al.49 https://relion.readthedocs.io/en/release-5.0/#
Bcl2fastq v2.19.1.403 Illumina N/A
PyRosetta Ref2015 Chaudhury et al.54 https://www.pyrosetta.org/
NanoScope Analysis v2.0 Bruker http://nanoscaleworld.brukeraxs.com/nanoscaleworld/media/p/775.aspx
EPU v2.8 Thermo N/A
ChimeraX v1.9 UCSF https://www.cgl.ucsf.edu/chimerax/
Coot v1.21 Emsley et al.52 https://www2.mrclmb.cam.ac.uk/personal/pemsley/coot/
Other

RESOURCES